Stroke experts to test emerging nerve stimulation treatment
New stroke therapy delivers electrical pulses to the brain
Read Moreby John Pinching | Jan 19, 2024 | News | 0
New stroke therapy delivers electrical pulses to the brain
Read Moreby John Pinching | Jan 19, 2024 | News | 0
Company will present vital findings at SRI annual meeting
Read Moreby John Pinching | Sep 27, 2023 | News | 0
Report shows that if the health service invests in community services hospital admissions will reduce
Read Moreby John Pinching | Jun 21, 2023 | News | 0
During research there were not any clinically-relevant adverse events or psychotomimetic effects
Read Moreby John Pinching | Jun 20, 2023 | News | 0
The treatment is administered intravenously prior to surgery, lighting up cancer during surgery
Read Moreby John Pinching | Jun 13, 2023 | News | 0
525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure
Read Moreby John Pinching | Jun 12, 2023 | News | 0
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor
Read Moreby John Pinching | Jun 9, 2023 | News | 0
Erdafitinib boosted survival in patients with certain conditions including metastatic urothelial carcinoma
Read Moreby John Pinching | Jun 6, 2023 | News | 0
Rocketvax and Basel University therapy uses a modified coronavirus that activates an immune response
Read Moreby John Pinching | May 19, 2023 | News | 0
Screening patients to assess their clopidogrel resistance status will allow for alternative treatments
Read Moreby John Pinching | May 18, 2023 | News | 0
The therapy is a brain-penetrant used in various combinations in patients with progressive glioblastoma
Read Moreby John Pinching | May 9, 2023 | News | 0
The therapy treats adults with chronic hepatitis delta virus and compensated liver disease
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479